胆碱酯酶活性与危重症脑功能障碍的关联
本研究纳入272例呼吸衰竭和/或休克成人患者,在入组后第1、3、5、7天测定血浆乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)活性,并计算AChE/血红蛋白比值。采用Richmond躁动镇静评分和ICU意识模糊评估法每日两次评估精神状态。多变量回归显示,每日AChE水平较高与同日谵妄(相对于正常精神状态)的 odds 增加相关(OR 1.64,95%CI 1.11–2.43;P=0.045),而AChE/Hgb和BChE与谵妄无关联;入组时BChE较低与无谵妄或无昏迷存活天数较少相关(P=0.048)。AChE、AChE/Hgb和BChE均与出院后认知障碍、残疾或生活质量无显著关联。
要点
- 每日AChE水平较高与同日谵妄风险增加独立相关(OR 1.64,95%CI 1.11–2.43;P=0.045)。
- AChE/Hgb和BChE活性水平与谵妄状态无显著关联。
- 入组时BChE较低与无谵妄或无昏迷存活天数较少相关(P=0.048)。
- AChE、AChE/Hgb及BChE水平与出院后认知障碍、残疾或生活质量无显著关联。
- 作者认为胆碱酯酶活性与危重症期间谵妄相关,但不与出院后结局相关,可能反映急性脑器官功能障碍机制。
适用人群与场景
- 纳入呼吸衰竭和/或休克的成人危重症患者,中位年龄56(IQR 39–67)岁,入组时中位SOFA评分8(5–11)。
诊断标准与关键阈值
- 采用Richmond躁动镇静评分和ICU意识模糊评估法每日两次评估昏迷和谵妄,以判定每日精神状态(谵妄、昏迷、正常)。
研究设计与关键结果
- 研究纳入272例危重症患者,于入组后第1、3、5、7天测定血浆AChE和BChE活性,并计算AChE/Hgb比值;出院后至6个月评估认知障碍、残疾和健康相关生活质量。
- 每日AChE水平较高与同日谵妄(相对于正常精神状态)的 odds 增加相关:OR 1.64(95%CI 1.11–2.43),P=0.045。
- AChE/Hgb和BChE活性水平与谵妄状态无显著关联。
- 入组时BChE较低与无谵妄或无昏迷存活天数较少相关(P=0.048)。
- AChE、AChE/Hgb和BChE水平与出院后认知障碍、残疾或生活质量无显著关联。
证据类型、等级与局限
- 证据类型:前瞻性队列研究(注册号NCT03098472,注册日期2017年3月31日)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为危重症期间胆碱酯酶活性与谵妄相关但不与出院后结局相关,该发现可能反映急性脑器官功能障碍的机制。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Delirium is a frequent manifestation of acute brain dysfunction and is associated with cognitive impairment. The hypothesized mechanism of brain dysfunction during critical illness is centered on neuroinflammation, regulated in part by the cholinergic system. Point-of-care serum cholinesterase enzyme activity measurements serve as a real-time index of cholinergic activity. We hypothesized that cholinesterase activity during critical illness would be associated with delirium in the intensive care unit (ICU) and cognitive impairment after discharge.
METHODS: We enrolled adults with respiratory failure and/or shock and measured plasma acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activity on days 1, 3, 5, and 7 after enrollment. AChE values were also normalized per gram of hemoglobin (AChE/Hgb). We assessed for coma and delirium twice daily using the Richmond Agitation Sedation Scale and the Confusion Assessment Method for the ICU to evaluate daily mental status (delirium, coma, normal) and days alive without delirium or coma. Cognitive impairment, disability, and health-related quality of life were assessed at up to 6 months post-discharge. We used multivariable regression to determine whether AChE, AChE/Hgb, and BChE activity were associated with outcomes after adjusting for relevant covariates.
RESULTS: We included 272 critically ill patients who were a median (IQR) age 56 (39-67) years and had a median Sequential Organ Failure Assessment score at enrollment of 8 (5-11). Higher daily AChE levels were associated with increased odds of being delirious versus normal mental status on the same day (Odds Ratio [95% Confidence Interval] 1.64 [1.11, 2.43]; P = 0.045). AChE/Hgb and BChE activity levels were not associated with delirious mental status. Lower enrollment BChE was associated with fewer days alive without delirium or coma (P = 0.048). AChE, AChE/Hgb, and BChE levels were not significantly associated with cognitive impairment, disability, or quality of life after discharge.
CONCLUSION: Cholinesterase activity during critical illness is associated with delirium but not with outcomes after discharge, findings that may reflect mechanisms of acute brain organ dysfunction.
TRIAL REGISTRATION: NCT03098472. Registered 31 March 2017.
参考来源
- Hughes CG, Boncyk CS, Fedeles B, et al. Association between cholinesterase activity and critical illness brain dysfunction. Crit Care. 2022. PMID: 36474266. doi:10.1186/s13054-022-04260-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。